INTRODUCTION
The mechanism of circadian oscillators in mammals is generated by a cell autonomous autoregulatory transcription-translation feedback loop (Lowrey and Takahashi, 2004; Reppert and Weaver, 2002) . In the primary negative feedback loop, the bHLH-PAS transcription factors, CLOCK (and its paralog NPAS2) and BMAL1 (ARNTL) dimerize and activate transcription of the Period (Per1, Per2) and Cryptochrome (Cry1, Cry2) genes (Bunger et al., 2000; Gekakis et al., 1998; King et al., 1997; Kume et al., 1999) . As the PER proteins accumulate, they form complexes with the CRY proteins, translocate into the nucleus, and interact with the CLOCK/BMAL1 complex to inhibit their own transcription (Lee et al., 2001) . This leads to a fall in the inhibitory complex through turnover, and the cycle starts again with a new round of CLOCK/BMAL1-activated transcription. Additional pathways in the circadian gene network, such as the second negative feedback loop (involving Rev-erba) in the positive limb of the oscillator, are thought to add robustness to the circadian mechanism (Preitner et al., 2002; Sato et al., 2004) . Finally, posttranslational modifications play critical roles in regulating the turnover, cellular localization, and activity of circadian clock proteins (Eide et al., 2005; Gallego and Virshup, 2007; Lowrey et al., 2000) .
Despite this progress, it is clear that a significant number of genes that strongly influence and regulate circadian rhythms in mammals remain to be discovered and identified (Shimomura et al., 2001; Takahashi, 2004) . Forward genetic screens have been one of the most effective tools for circadian gene discovery (Takahashi, 2004; Takahashi et al., 1994; Vitaterna et al., 1994) , and we have used this approach to screen the mouse genome for circadian rhythm mutants generated in the Neurogenomics Project in the Center for Functional Genomics at Northwestern University (Vitaterna et al., 2006) .
Using a forward genetic approach in mice, we report here the isolation and positional cloning of a novel circadian period mutant in mice. This mutation reveals a defect in an orphan member of the F-box protein family, FBXL3, which leads to a stabilization of CRY protein levels and a global repression of Per and Cry gene transcription.
with a 25.8 hr period length, which is more than 10 standard deviations from the mean in this screen (Figure 1 ). This mutant, named Overtime, is semidominant and autosomal. In crosses with C57BL/6J and C3H/HeJ mouse strains, the homozygous mutant phenotype is distinct with an average circadian period of 26.2 hr and a range of about 25-28 hr, which is indistinguishable from the original mutant (Figures 2A-2D) . Ovtm maps to a 1.7 cM interval on chromosome 14 between D14Mit265 (5 recombinants/642 meioses) and D14Mit197 (6 recombinants/642 meioses) ( Figure 2E ). This region corresponds to a 4 Mb interval and contains 18 open reading frames (Assembly build NBI m36 December 2005, Gene build June 2006), none of which corresponds to previously known circadian clock genes ( Figure 3A ) (Lowrey and Takahashi, 2004) .
Several genes in the nonrecombinant interval were likely candidates for Ovtm. Protein degradation machinery has as an important role in the clock mechanism (Gallego and Virshup, 2007) , and there are several ubiquitin-pathway related genes in this interval (Uch13, Lmo7, Fbxl3, Phr1, 2610206B13Rik, and Ndfip2) . Because the entire 4 Mb Ovtm interval has a low polymorphism rate and shares the identical haplotype with the mapping strains, the resolution of meiotic mapping could not be increased. This region of the genome is part of the piebald deletion complex, which contains several developmentally important genes (Peterson et al., 2002) . This may have caused selection of a limited number of ancestral haplotypes in this region of chromosome 14, which would in turn lead to a low polymorphism rate.
We sequenced all annotated exons for the 18 candidate genes in the Ovtm interval and found only a single nonsynonymous point mutation within the coding region of Fbxl3. There is a single base transition from A to G in exon 5 of Fbxl3 in Ovtm mice as compared to wild-type BTBR/J mice. This mutation cosegregated perfectly with the long-period phenotype of Ovtm/Ovtm mice (0 recombinations out of 642 meioses; Figures 2D and 2E) . The point mutation converts amino acid residue 364 from isoleucine to threonine in FBXL3 (Figures 3A and 3B) . This isoleucine residue is highly conserved in FBXL3 from vertebrates and in the mouse paralog FBXL21 ( Figure 3B ). FBXL3 is a member of the F-box protein family with leucine rich repeats (LRR), which is defined by its founding member, SKP2 (S-phase kinase-associated protein-2) (FBXL1) (Jin et al., 2004) . SKP2 is the F-box protein moiety in the SKP1-CUL1-F-box-protein (SCF) SKP2 E3 ubiquitin ligase complex, which mediates the recognition and ubiquitination of the CDK2 inhibitor, p27 Kip1 , to target it for proteasomal degradation . Structural studies show that CUL1 provides a rigid scaffold, upon which SKP1 and RBX1 subunits assemble: (D) Period distribution of F2 intercross progeny. The three panels from top to bottom represent wild-type, Ovtm/+, and Ovtm/Ovtm mice, respectively. Analysis of variance (ANOVA) of the periods was performed on the three populations of F2 mapping mice (as defined by Ovtm genotype). Significant effects of the Ovtm allele were detected (DF = 2; F = 2112; p < 1 3 10 À27 ).
(E) Ovtm maps between D14Mit265 and D14Mit197. The chromosome 14 schematic lists the distal markers used to map Ovtm. Haplotypes of the 321 Ovtm/Ovtm F2 intercross progeny (642 meioses) are on the right. Black boxes represent BTBR/J alleles, while gray boxes represent heterozygous alleles (BTBR/J and C57BL/6J). The number of recombinants per total meioses is indicated to the right of the haplotype map. (Jin et al., 2004) . b strand (blue arrow) and a-helical (red ovals) regions (based on analysis using PROF in the PredictProtein server [Rost et al., 2004] ) of LRR10 and LRR11 are indicated above the sequence. In the protein alignment, yellow indicates amino acid identity, green indicates conservative substitutions, white indicates nonconservative substitutions, and red indicates the I364T Ovtm mutation.
SKP1 interacts with SKP2 via its N-terminal F-box motif (Zheng et al., 2002) . Recent work shows that the LRR region and the C-terminal tail of SKP2 interact with the substrate, p27 Kip1 , and the accessory protein, CKS1 (Hao et al., 2005) . FBXL3, which has 11 LRRs, can be aligned with SKP2, which has 10 LLRs based on its protein structure; however, the C termini of SKP2 and FBXL3 are not conserved, likely due to the recognition of different substrates (Hao et al., 2005) . The Ovtm I364T mutation occurs in the C terminus of FBXL3 between LRR10 and LRR11, where the alignment with SKP2 becomes divergent (Figure 3B) . Because the LRR domains of F-box proteins are involved with substrate recognition with the SCF complex, we hypothesized that the I364T mutation could alter the interaction of FBXL3 with its substrates.
Because we isolated only one mutant allele of Fbxl3 and either a second independent allele, rescue, or functional evidence is required for proof in positional cloning , we used genetic complementation tests to confirm that Ovtm was allelic with Fbxl3. A search of the International Gene Trap Consortium (IGTC) database (http://www.genetrap.org/) revealed three gene traps in Fbxl3, and we obtained one gene trap ES cell line (S13-12G1) from Philippe Soriano (Chen et al., 2004) . ES cells were microinjected into blastocysts to produce chimeras, and 19 out of 19 mice were chimeric. Because the ES cell contribution in these chimeras was >95%, they were mated directly to Ovtm/Ovtm mice to test for germline transmission and genetic complementation simultaneously. The crosses show that Ovtm and the Fbxl3 gene trap (GT) fail to complement each other, thus providing independent and definitive evidence that Ovtm is an allele of Fbxl3 ( Figure 3C ). Interestingly, the period length of GT/Ovtm mice is indistinguishable from Ovtm homozygotes, suggesting that the Ovtm mutant allele is likely a hypomorphic or loss-of-function allele.
The mRNA expression of Fbxl3 itself in the mouse is ubiquitous, but enriched in the brain (data not shown). Northern blot analysis of Fbxl3 from liver in wild-type (WT) and Ovtm mice did not reveal any significant differences in transcript size or abundance between the genotypes. In addition, there was no obvious circadian rhythm in Fbxl3 mRNA expression in the liver. In situ hybridization of Fbxl3 shows clear RNA expression in the suprachiasmatic nucleus (SCN) and throughout the brain (see Supplemental Data) .
Effects of the Overtime Mutation on Circadian Clock Gene Expression
Because FBXL3 is likely a component of an SCF E3 ubiquitin ligase complex, we examined the in vivo expression patterns of circadian clock proteins in mouse tissues to explore whether Ovtm might alter their abundance by affecting degradation. WT and Ovtm mice were housed in running wheel cages to measure activity rhythms and were transferred to constant darkness (DD) for 10-14 days. Animals were killed under infrared illumination every 3 hr in DD based on circadian time (CT) to compensate for the differences in circadian period between WT and Ovtm mice. Figure 4A shows the expression patterns of the clock proteins, CRY1, CRY2, PER1, PER2, CLOCK, and BMAL1 in liver and cerebellum. In WT mice, there were low amplitude rhythms of CRY1 and CRY2 and high amplitude rhythms of PER1 and PER2 as reported previously (Lee et al., 2001) . In Ovtm liver tissue, CRY1 and CRY2 protein patterns were not significantly altered; however, PER1 and PER2 levels were significantly reduced ( Figure 4B ). In the cerebellum, the effects of Ovtm were more striking. Although CRY1 levels were not different, CRY2 levels were significantly elevated in Ovtm mice consistent with the hypothesis that CRY degradation is impaired. In addition, there were very clear reductions in the levels of PER1 and PER2. The levels of CLOCK and BMAL1 were not detectably changed in either tissue in Ovtm mice ( Figure 4A ). The reduction of PER1 and PER2 levels in Ovtm mice is significant in both liver and cerebellum, and this finding is unexpected and counterintuitive. We would have expected to see an increase rather than a decrease in protein abundance if the PER proteins were targets of FBXL3 because the Ovtm mutation is a loss-of-function mutation. This suggests that it is unlikely that the PER proteins are targets of FBXL3 and that the reduction in PER levels could occur as a consequence of the negative feedback on CLOCK/BMAL1-dependent transcription.
To explore the reasons for the reduction in PER1 and PER2 protein abundance, we profiled the in vivo circadian mRNA expression patterns for Cry1, Cry2, Per1, Per2, and Dbp in the liver and cerebellum of mice maintained in DD. As shown in Figure 4C , the Ovtm mutation caused significant reductions in the mRNA abundance of all of these cycling transcripts with the strongest effects being seen with Cry1 and Per2 in the cerebellum. At the mRNA level, both a delay in the peak time and a reduction in abundance can be seen. Importantly, although CRY1 and CRY2 protein levels were not lower in Ovtm mice, the corresponding mRNA levels for Cry1 and Cry2 are significantly reduced in both tissues. Similar reductions in the mRNA levels for Cry1 and Per2 in Ovtm mice could also be observed in the SCN using in situ hybridization (see Supplemental Data). In addition, mRNA levels for the cycling CLOCK target gene, Dbp (Ripperger and Schibler, 2006) , were very strongly reduced in Ovtm mice. Thus, the mRNA profiling experiments point to an interesting and unexpected consequence of the Ovtm mutation: a . Two-way ANOVA shows significant statistical differences between WT and Ovtm mutant for both PER1 and PER2 expression in cerebellum (p < 0.001 and p < 10 À5 , respectively) and in liver (p < 10 À5 and p < 0.001, respectively). In contrast to PER, only CRY2 shows a significant difference in expression from cerebellum (p < 10 À5 ) between wild-type and Ovtm mice.
reduction in steady-state mRNA expression of Cry1, Cry2, Per1, Per2, and Dbp, which are all transcriptional targets of the CLOCK/BMAL1 complex (Gekakis et al., 1998; Kume et al., 1999; Ripperger and Schibler, 2006; Yoo et al., 2005) .
Comparison of the effects of Ovtm on protein versus mRNA abundance suggests that there are two different effects on the expression of the CRY and PER proteins. The PER protein levels appear to be reduced as a consequence of reduced transcript levels. By contrast, the CRY protein levels are not reduced, even in the face of reduced transcript levels. This suggests that potential reductions in CRY protein levels caused by reduced Cry transcript levels could be compensated by a reduction in protein degradation.
Interaction of OVTM with Circadian Clock Proteins
The Pagano laboratory has found that FBXL3 targets CRY proteins for ubiquitination and degradation (personal communication). To confirm these results and determine whether the Ovtm mutation affects interactions with CRY, we examined the interaction of FBXL3 or OVTM with circadian clock proteins by immunoprecipitation assays. First, we used tagged Fbxl3, Ovtm, and bTrCP1 expression constructs to transfect NIH 3T3 cells, which contain circadian oscillators and express clock proteins (Nagoshi et al., 2004) . Cell lysates were immunoprecipitated with anti-FLAG or anti-V5 antibodies, and interactions with CRY1, CRY2, PER1, and PER2 native proteins were probed on western blots ( Figure 5A ). Both FBXL3 and OVTM interacted strongly with native CRY1 and CRY2 proteins. Very weak or no interaction of FBXL3 was seen with PER1 and PER2, especially in comparison to that seen between the PERs and bTrCP1, an F-box protein known to interact with the PERs (Eide et al., 2005; Shirogane et al., 2005) ( Figure 5A ). In all experiments, there was a discernibly stronger interaction of the CRY proteins with FBXL3 relative to OVTM, but the difference was subtle.
We also used tagged proteins in coimmunoprecipitation assays in 293A cells, which are easily transfected and express relatively low levels of clock proteins. Both FBXL3 and OVTM interacted strongly with CRY1 and CRY2 (Figure 5B) . To explore the weak interaction of FBXL3 with PER proteins, tagged Per constructs were also tested. All three PER proteins showed interactions with FBXL3 and OVTM; however, the strongest interactions were seen with PER2. Because PER2 interacts very strongly with CRY1 (Griffin et al., 1999; Kume et al., 1999; Lee et al., 2001) , it is likely that the interactions seen here with FBXL3 may be indirect via CRY1.
Effects of OVTM on CRY Degradation
To determine whether OVTM is less efficient than FBXL3 in inducing the degradation of CRY1, we compared the effects of FBXL3 and OVTM on the stability of CRY1 following cycloheximide treatment to prevent de novo protein synthesis in transfected cells ( Figure 5C ). In 293A cells, transfected CRY1 is relatively stable with a half-life of 6.4 hr ( Figure 5D ). Addition of FBXL3 or OVTM increased the turnover of CRY1 significantly with FBXL3 leading to a 1.7 hr CRY1 half-life and OVTM leading to a 2.5 hr CRY1 half-life ( Figure 5D ). Thus, FBXL3 expression leads to the degradation of CRY1, and this degradation is blocked by the 26S proteasomal inhibitor MG132 ( Figure 5C ). OVTM is less effective than FBXL3 in causing CRY1 degradation under these conditions, and the half-life parameter, K, is significantly different (p = 0.016) between FBXL3 and OVTM in the model-based nonlinear exponential decay analysis with GraphPad Prism 4. Interestingly, the turnover of FBXL3 is also affected by the OVTM mutation (Figure 5C ; bottom). FBXL3 is relatively stable with a half-life of greater than 7 hr; whereas, OVTM has a much shorter halflife of 2.7 hr ( Figure 5D ). Therefore, there are two effects of the OVTM mutation: (1) a reduction in proteasome-mediated CRY1 degradation and (2) a decreased stability of the OVTM protein itself, both of which could contribute to a loss-of-function phenotype.
To determine whether these changes in CRY1 stability seen in transfected cells are physiological, we used fibroblasts prepared from either WT or Ovtm mice and determined the half-lives of native CRY1 and PER2 proteins in these cells. Fibroblast cultures were synchronized with 10 mM forskolin and treated with cycloheximide. The halflives of CRY1 and PER2 were then determined by western blot against native proteins. As shown in Figures 5E and 5F, the half-life of CRY1 in Ovtm fibroblasts is extremely long (>9 hr), as compared to WT cells (half-life = 5.2 hr). The overall levels of PER2 in Ovtm fibroblasts were very low, similar to that seen in the cerebellum. When the halflife of PER2 was determined, however, there was no detectable difference in the half-life of PER2 in WT and Ovtm cells ( Figure 5F ). Thus, these experiments in fibroblasts from WT and Ovtm mice show that native CRY1, but not PER2, turnover is specifically altered by the Ovtm mutation. These experiments strongly suggest that OVTM is selectively defective in its ability to target CRY1 for degradation by the proteasome.
Effects of Ovtm on Per and Cry Transcription
To understand why the steady-state transcript levels of Per and Cry are reduced in Ovtm mice, we estimated transcription rates by measurement of pre-mRNA levels and mRNA stability by half-life experiments. In both liver and cerebellum, Cry1 and Per2 pre-mRNA levels are strongly correlated with steady-state mRNA abundance levels with lower pre-mRNA levels observed in Ovtm tissue (Figure 6A) . As seen for steady-state mRNA levels, the reduction in Cry1 and Per2 pre-mRNA levels was most clear in the cerebellum. Thus, Ovtm strongly reduces the transcription of Cry1 and Per2 in vivo, consistent with the hypothesis that transcription rates account for the reduction in steady-state mRNA abundance. To reinforce this hypothesis, we also measured the half-lives of mRNAs for Cry1, Cry2, Per1, and Per2. WT and Ovtm fibroblasts were treated with Actinomycin D to inhibit de novo transcription, and mRNA half-life was determined by quantitative PCR. As shown in Figure 6B , although there are differences in the initial mRNA levels of Cry1 and Per2 as seen in the cerebellum, the half-lives of all four transcripts are not significantly different in WT and Ovtm cells using modelbased nonlinear exponential decay analysis with GraphPad Prism 4. Thus, taken together, these experiments argue that the reduced mRNA levels of the Cry and Per genes in Ovtm mouse tissues are due to a reduction in transcription of these genes.
To address the functional consequences of the mutation, we assessed whether Fbxl3 or Ovtm could affect Clock/Bmal1-mediated transcriptional activation. We asked whether Fbxl3 or Ovtm could modulate the inhibitory effects of Cry1 on Clock/Bmal1-induced transcription using a Per2 E2 enhancer driving luciferase (Yoo et al., 2005) . In Figure 6C , Clock/Bmal1 transfection activates luciferase activity $6-fold. As recently reported (Kwon et al., 2006) , treatment with the proteasomal inhibitor MG132 significantly reduces the magnitude of Clock/Bmal1 activation. As expected, Cry1 cotransfection strongly inhibited Clock/Bmal1 activation (Griffin et al., 1999; Kume et al., 1999) . The addition of Fbxl3 strongly diminished the Cry1-dependent inhibitory effects on Clock/Bmal1 activation, while addition of Ovtm was much less effective than that seen with Fbxl3. Western blots confirmed that the expression levels of FBXL3 and OVTM were comparable. However, Fbxl3 and Ovtm transfection reduced the levels of CRY1, consistent with the CRY1 degradation experiments in Figure 5C . Thus, FBXL3 and OVTM both reduced CRY1 expression levels, and the reduction in CRY1 is correlated with a reduction in CRY1-dependent inhibition of CLOCK/BMAL1 activation (linear regression analysis of CRY1 level versus PER::LUC activity: slope is significant; p = 0.0181; Pearson's correlation coefficient R = À0.67). Thus, one possible explanation for the difference in CLOCK/BMAL1-dependent transcription in WT and Ovtm tissues could be that FBXL3 normally provides a steady-state turnover of CRY via proteasomal degradation that is reduced by the Ovtm mutation. This could then lead to an accumulation of CRY to suppress CLOCK/ BMAL1-dependent transcription.
DISCUSSION
We have shown that the ENU-induced Overtime mutant is caused by an I364T mutation in the mouse FBXL3 protein, a member of the F-box protein with leucine rich repeats family (Jin et al., 2004) . The OVTM protein is less efficient than FBXL3 in degrading CRY1, thus providing genetic evidence that FBXL3 appears likely to be a primary F-box protein within an SCF E3 ubiquitin ligase complex ) that targets the CRY proteins for degradation in the proteasome. The I364T OVTM mutation lengthens circadian periodicity $2.5 hr in mice. We propose that the phenotypic effects of the Ovtm mutation occur primarily through two mechanisms: (1) loss of FBXL3 function leading to stability of CRY1 protein and (2) repression of CLOCK/BMAL1-dependent transcriptional activation. These two processes lead to a striking reduction in the expression of the PER proteins, which is caused by a reduction in transcription of the Per genes. By contrast, the levels of CRY are not reduced by the Ovtm mutation despite lower rates of Cry transcription. Indeed in the cerebellum, the level of CRY2 protein is significantly higher as expected (perhaps due to the slightly higher relative rate of transcription of Cry2 compared to Cry1 in the cerebellum in Ovtm versus WT mice). However, the levels of CRY1 protein were not elevated in Ovtm mice. Because the majority of CRY protein is cytoplasmic (Lee et al., 2001) , we also examined levels of CRY1 in the nucleus but did not detect an increase in CRY levels in nuclear fractions from the liver of Ovtm mice in comparison to WT (data not shown). In retrospect, because the transcription of the Cry1 gene is strongly attenuated by the Ovtm mutation, it is surprising that CRY1 protein levels are not lower. The low rate of CRY1 protein degradation in Ovtm tissues must offset the lower synthesis of CRY1 so that the steady-state abundance of CRY1 protein is similar in Ovtm and WT mice. Importantly however, because the turnover rate of CRY1 is reduced, the clearance of CRY1 will be prolonged even if the initial steady-state abundance levels are comparable. This would then lead to a prolongation of the CRY-dependent repression phase of the circadian cycle. If such a prolongation extended CRY repression for 2-3 hr, the period-lengthening phenotype seen in Ovtm mice would follow as a consequence. It will be of great interest to test existing biochemical models of the circadian oscillator (Forger and Peskin, 2003; Leloup and Goldbeter, 2004) for these phenotypic effects. In particular, it will be important to determine whether global changes in the set point for transcription rates of (E) Stability of endogenous CRY1 and PER2 in Ovtm ear fibroblast cells. WT and Ovtm fibroblast cells were plated 48 hr before the experiment and synchronized by 1 hr treatment with 10 mM forskolin. A total of 20 mg/ml CHX was administered during indicated time. Protein extracts from harvested cells were analyzed with western blotting using anti-CRY1 and anti-PER2 antibody. a-tubulin was used as a loading control. the clock genes occur as a result of decreases in the degradation of the CRY proteins and whether the changes in CRY turnover rates can account for the period-lengthening phenotype of Ovtm mice. In addition, it will be interesting to explore the reasons underlying the tissue-specific differences observed in Ovtm mice.
These results highlight the significance of an SCF FBXL3 E3 ubiquitin ligase complex in regulating the stability and kinetics of CRY degradation. The specificity of the FBXL3 interaction with the CRY proteins is striking and suggests that additional F-box proteins may regulate other circadian clock components. The first example of an F-box protein playing a role in circadian rhythmicity was the Arabidopsis gene ZEITLUPE (ZTL), which encodes an F-box protein with an N-terminal LOV domain and C-terminal kelch repeats (Somers et al., 2000) . ZTL targets the Arabidopsis clock protein, TOC1, for degradation by the proteasome and is thought to regulate circadian period by controlling TOC1 stability (Mas et al., 2003) .
In addition, the F-box protein, FKF1, mediates the cyclic (B) mRNA half-life measurements of Cry1, Cry2, Per1, and Per2. WT and Ovtm fibroblast cells were plated 48 hr before, then treated with 5 mg/ml Actinomycin D for indicated amount of time. Total RNA was isolated from the harvested cells, and quantitative PCR was performed as described previously. There were no significant differences in mRNA half-lives between WT and Ovtm cells.
(C) Effects of FBXL3 on CLOCK/BMAL1-mediated transcriptional activation. pGL3Basic-E2 was transfected into 293A cells with the indicated DNA constructs (plus sign). Each value represents the mean ± SEM of three replicates from a single experiment. The results shown are representative of at least three independent experiments. The lower panel shows western blots from the same extracts used in the luciferase assays. Anti-HA and anti-FLAG antibodies were used to detect CRY1-HA and FBXL3, OVTM-FLAG, respectively.
degradation of CDF1, a repressor of the photoperiodic gene CONSTANS (Imaizumi et al., 2005) , and the F-box protein, AFR, is a positive regulator of phytochrome A-mediated light signaling in Arabidopsis (Harmon and Kay, 2003) . FBXL3 is the second example of a mammalian F-box protein regulating the circadian clock proteins. The first example is bTrCP, which has been shown to interact directly with the PER proteins (Eide et al., 2005; Shirogane et al., 2005) . Evidence for bTrCP in the circadian pathway first emerged from Drosophila in which it was shown that Slimb, the ortholog of bTrCP, regulated circadian expression of PER and TIM (Grima et al., 2002; Ko et al., 2002) . Interestingly, in Neurospora, the ortholog of bTrCP, FWD1, regulates the degradation of the clock protein, FRE-QUENCY (He et al., 2003) . More recently, JETLAG, the Drosophila ortholog of Fbxl15, has been shown to play a critical role in light-induced TIM degradation by the proteasome (Koh et al., 2006) . In Drosophila two different SCF complexes appear to control TIM levels: (1) a circadian pathway involving Slimb and (2) a light-dependent pathway involving JET (Koh et al., 2006) . It will be interesting see whether similar types of mechanisms are conserved in mammals. Because of the differences in the roles of the PER and CRY proteins in Drosophila and in mammals (Allada et al., 2001; Young and Kay, 2001) , where CRY is primarily a circadian repressor (not a photoreceptor), FBXL3 appears to function in a circadian SCF complexmediated pathway. Unlike Drosophila PER, the PER1 and PER2 proteins in mammals are transcriptionally induced by light in the SCN. It will be interesting to see whether bTrCP functions in a circadian or in a light-dependent SCF pathway for PER degradation (analogous to the TIM protein in Drosophila). Using a forward genetics approach in mice, we have identified FBXL3 as a new molecular component of the negative feedback loop that generates circadian rhythmicity. Our results both confirm biochemical studies from the laboratory of Pagano (personal communication) showing that the SCF FBXL3 E3 ubiquitin ligase complex targets CRY1 for ubiquitination and provide in vivo evidence that links CRY stability to CLOCK/BMAL1-mediated transcriptional activation. In Ovtm mice the fine equilibrium between activation and repression of clock gene transcription is disturbed due to the mutation. Future studies will further clarify how this equilibrium between activators and repressors leads to the generation of circadian periodicity.
EXPERIMENTAL PROCEDURES
Mouse Strains BTBR T + tf/J (Stock #002282), C57BL/6J (Stock # 000664), C3H/HeJ (Stock # 000659), and 129S1/SvImJ (Stock #002448) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). CD-1 (Strain code 022) female mice were purchased from Charles River Laboratories (Wilmington, MA). All mice were housed under LD12:12 unless otherwise noted. All animal care and experimental treatments were in accordance with Northwestern University guidelines for animal care and use.
Mutagenesis and Breeding Scheme N-Ethyl-N-nitrosourea (ENU) (Sigma cat #N3385) was prepared as described previously (Siepka and Takahashi, 2005a) . Six-week-old male BTBR/J mice were injected with 250 mg/kg body weight of ENU. After a 6-week recovery period, the ENU-treated mice were mated with wild-type BTBR/J females to generate generation 1 (G1) males. G1 males were mated with wild-type BTBR/J females to produce G2 females. Four G2 females were backcrossed to their G1 fathers to produce G3 mice for phenotyping. Five G3 mice from every G2 backcross (20 mice per G1 pedigree) were phenotyped to ensure an 85% probability of detecting a recessive mutation. 3198 G3 mice from 216 G1 pedigrees were successfully screened from a total of 3609 G3 mice produced.
Measurement of Free-Running Period
Mice (6-10 weeks of age) were placed in individual running wheel cages, and activity was recorded using the ClockLab data collection system (Actimetrics, Wilmette, IL). After 1 week on LD12:12, the mice were released into constant darkness (DD) for an additional 3 weeks. Free running period was measured by linear regression analysis of activity onsets from data collected during the DD portion of the assay using ClockLab software (Siepka and Takahashi, 2005b) .
Genetic Mapping
Ovtm/Ovtm male mice were mated to C3H/HeJ female mice to create (Ovtm/+ 3 C3H/HeJ) F1 mice. The F1 females were backcrossed to produce 156 ([Ovtm/+ 3 C3H/HeJ] 3 Ovtm/Ovtm) N2 mice for mapping. Alternately, Ovtm/Ovtm female mice were mated to C57BL/6J male mice to create (Ovtm/+ 3 C57BL/6J) F1 mice. These F1 siblings were intercrossed to produce 1480 (Ovtm 3 C57BL/6J) F2 mice for mutation mapping. Wheel-running behavior of all mapping mice was collected and analyzed as described above. Only presumptive Ovtm homozygous mice (321 genotyped for a total of 642 meioses) were used for genetic mapping as described in the Supplemental Data.
Sequencing of Candidate Genes
Sequencing was performed either in our laboratory or at the Harvard Partners Genome Center, Cambridge MA. Genomic DNA was extracted from tail tips from two wild-type BTBR/J mice and two Ovtm/ Ovtm mice. All annotated exons from MGSC 36 within the 4 MB interval between D14Mit265 and D14Mit197, which contains Ovtm, were amplified by PCR using genomic DNA templates. Most exons were small enough to be amplified and sequenced in a single amplicon ($600 bp). Some larger exons however, were sequenced by multiple overlapping 600 bp amplicons. (Chen et al., 2004 ) that disrupts expression of Fbxl3 to create a null allele of Fbxl3. The maintenance of ES cells, production of chimeric mice, and genotyping of the Fbxl3 gene trap are described in the Supplemental Data.
Immunoblotting and Immunoprecipitation
Immunoblotting was performed as described previously (Yoo et al., 2004) . Antibodies against PER1, PER2, CRY1, CRY2, CLOCK, and BMAL1 were made as described previously (Lee et al., 2001 ). Immunoprecipitation was performed 32 hr after transfection including an 8 hr treatment of 20 mM MG132 (EMD Biosciences). Harvested cells were homogenized in EB (20 mM HEPES at pH 7.5, 100 mM NaCl, 0.05% TritonX-100, 1 mM EDTA, 20 mM NaF, 1 mM Na 3 OV 4 , Complete mini, Roche) and centrifuged at maximum speed for 10 min at 4 C.
The supernatants were transferred to fresh tubes and incubated with 2 mg of anti-FLAG or anti-V5 antibodies for 2 hr at 4 C. Ten microliters of 50% protein-A slurry (GE) was added, and the incubation continued for an additional 1.5 hr. Supernatants were discarded after centrifugation at 3000 rpm at 4 C for 1 min, and protein-A beads were washed three times with 1 ml EB. Pellets were resuspended in 20 ml of 2 X SDS sample buffer and boiled for 3 min. Protein samples were separated by 10% or 6% SDS-polyacrylamide gel and then transferred to a nitrocellulose membrane (NEN). Five percent nonfat dry milk in Tris-buffered saline containing 0.05% Tween20 was used for blocking buffer. Anti-HA (Roche), anti-FLAG (Sigma), and anti-V5 (Invitrogen) were used to detect CRY1, FBXL3 (or OVTM), and bTRCP1, respectively.
RNA Isolation and Real-Time PCR Total RNA was isolated from frozen tissues with Trizol reagent (Invitrogen), then treated with DNase (Ambion). A total of 0.5 mg DNasetreated total RNA was reverse transcribed using Taqman reverse-transcription reagent (Roche). The cDNA equivalent to 10 ng of total RNA was PCR-amplified in either an ABI Prism 7700 Sequence Detector or an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems, Inc.). RNA expression was quantified by using SYBR green real-time PCR analysis. Analysis was performed as described previously (Wilsbacher et al., 2002) . Primer sequences are described in the Supplemental Data.
Cell Culture and Transfection Primary fibroblasts were isolated from the ear tissue of wild-type and Ovtm mutant mice. Briefly, minced ear tissue was incubated with collagenase III (1 mg/ml) and trypsin (0.05%). After 10 min incubation at 37 C minced tissue was allowed to adhere onto a 100 mm culture dish. Approximately 10 days after culture in DMEM (Mediatech) supplemented with 10% fetal bovine serum, ear fragments were removed, and outgrowing fibroblasts were replated into T75 flasks by trypsinization. NIH 3T3 and 293A (ATCC) cells were cultured in DMEM (Mediatech) supplemented with 10% fetal bovine serum. For immunoprecipitations, 1 3 10 6 cells were plated into the 100 mm dishes 1 day before transfection, Effectene reagent (Qiagen) was used to transfect DNA according to the manufacturer's protocol. For the luminescence assay, 293A cells were plated the day before transfection at 2 3 10 5 cells per well in 6-well plates. Cells were transfected with indicated vectors by using Effectene reagent. Forty-eight hours after transfection, cells were lysed and luminescence was measured from 20 ml of lysate in the Luciferase Assay System (Promega) using a luminometer (AutoLumet Plus; Berthold Technologies).
Supplemental Data
Supplemental Data include one figure, Supplemental Experimental Procedures, and Supplemental References and can be found with this article online at http://www.cell.com/cgi/content/full/129/5/1011/ DC1/.
